Indications for BCG use in carcinoma in situ.
Brosman
S A
SA
Department of Urology, Kaiser Hospital, Kaiser Medical Group, Los Angeles, California.
D001500:BCG Vaccine / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D015552:Injections, Intralesional; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000628:therapy*
D001500:BCG Vaccine